MedTrace Logo

REcanalization of Distal Cerebral Vessels in Acute Stroke Using ApeRio®

NCT04479020 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2024-12-06

No results posted yet for this study

Summary

The purpose of the REVISAR PMCF is to collect data in clinical practice of the APERIO® and APERIO® Hybrid(17) Thrombectomy Device, which are intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke. Recanalization status will be assessed at the end of the procedure using the modified TICI (Thrombolysis in cerebral infarction) score.

Conditions

  • Acute Stroke

Interventions

DEVICE

Mechanical Thrombectomy

Mechanical thrombectomy requiring the use an APERIO® or APERIO® Hybrid(17) Thrombectomy device due to an thrombotic occlusion in a distal vessel of the anterior and posterior circulation (postbifurcal MCA, ACA, PCA)

Sponsors & Collaborators

  • Acandis GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2024-01-30
Completion
2024-05-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04479020 on ClinicalTrials.gov